Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-01

Clinical Trial Update: A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of pemetrexed with cisplatin in non-small cell lung cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-01-01